Focused FDA Mock Review Module
For medical devices across all submission pathways, Panabistics reviews the risk management file against FDA expectations and produces a mock deficiency letter identifying likely review questions before submission.
Available Now. Expert-led, reviewer-style regulatory consulting.
Review Scope
| Area Reviewed | What We Assess |
|---|---|
| Risk management plan | Whether the risk management plan defines scope, responsibilities, criteria, and activities appropriate to the device and submission. |
| Hazard analysis | Whether hazards, hazardous situations, and harm are identified comprehensively and supported by the device description. |
| Risk controls | Whether risk control measures are appropriate, implemented, verified, and traceable to identified risks. |
| Residual risk | Whether residual risks are evaluated, disclosed, and acceptable in the context of device intended use. |
| Benefit-risk | Whether benefit-risk considerations are credible and supported by clinical, performance, and labeling evidence. |
| Traceability to V&V and labeling | Whether risk controls are linked to verification, validation, and labeling content throughout the submission. |
| ISO 14971 alignment | Whether the risk management process and file align with ISO 14971 expectations and FDA guidance. |
| eSTAR consistency | Whether risk management content aligns with software, cybersecurity, labeling, test evidence, and system description. |
Deliverables
FDA-style questions and deficiencies focused on likely risk management review concerns.
Excel-style tracker with issue, source, severity, regulatory basis, recommended fix, and owner field.
Clear readiness summary with go, conditional-go, or not-ready recommendation.
Prioritized steps to strengthen the risk management file before submission.
Support to revise documents, address gaps, and prepare stronger FDA-facing risk management evidence.
Audience
This service does not replace FDA review, risk analysis activities, design controls, legal advice, or the sponsor’s responsibility for submission content. It is an independent regulatory and submission-readiness review designed to identify likely FDA review concerns before submission. Panabistics does not represent FDA and does not guarantee clearance or approval.
This focused module can be commissioned independently or included as an applicable component of a broader Full eSTAR Mock Deficiency Review when the substantially complete submission package is available.
Explore the Full eSTAR Mock ReviewSelect a focused review module or explore the Full eSTAR Mock Deficiency Review for a broader submission-readiness assessment.
Request a Review
Tell us about your device, submission pathway, and risk management file. We will respond within 24 business hours.